Cell
Volume 186, Issue 13, 22 June 2023, Pages 2783-2801.e20
Journal home page for Cell

Article
NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs

https://doi.org/10.1016/j.cell.2023.05.005Get rights and content
Under a Creative Commons license
open access

Highlights

  • Cytosolic sensor NLRP12 drives lytic cell death in response to heme plus PAMPs/TNF

  • NLRP12 forms a PANoptosome with the inflammasome as an integral component

  • Caspase-8/RIPK3 drives PANoptosis downstream of the NLRP12-PANoptosome

  • NLRP12 is upregulated during hemolytic disease and induces pathology

Summary

Cytosolic innate immune sensors are critical for host defense and form complexes, such as inflammasomes and PANoptosomes, that induce inflammatory cell death. The sensor NLRP12 is associated with infectious and inflammatory diseases, but its activating triggers and roles in cell death and inflammation remain unclear. Here, we discovered that NLRP12 drives inflammasome and PANoptosome activation, cell death, and inflammation in response to heme plus PAMPs or TNF. TLR2/4-mediated signaling through IRF1 induced Nlrp12 expression, which led to inflammasome formation to induce maturation of IL-1β and IL-18. The inflammasome also served as an integral component of a larger NLRP12-PANoptosome that drove inflammatory cell death through caspase-8/RIPK3. Deletion of Nlrp12 protected mice from acute kidney injury and lethality in a hemolytic model. Overall, we identified NLRP12 as an essential cytosolic sensor for heme plus PAMPs-mediated PANoptosis, inflammation, and pathology, suggesting that NLRP12 and molecules in this pathway are potential drug targets for hemolytic and inflammatory diseases.

Keywords

NLRP12
heme
PAMP
DAMP
IRF1
hemolysis
inflammasome
inflammatory cell death
pyroptosis
apoptosis
necroptosis
caspase
gasdermin
TLR2
TLR4
caspase-8
caspase-1
RIPK3

Data and code availability

  • The datasets generated and analyzed during the current study are contained within the manuscript and accompanying extended data figures and tables, and publicly available datasets analyzed can be found in the Gene Expression Omnibus database: GSE133181, GSE34404, GSE136046, GSE102881, GSE168532, GSE58287, GSE40012, GSE171110. Data for patients with CCHFV was obtained from Sequence Read Archive (Accession: PRJNA680886).

  • This paper does not report original code.

  • Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon reasonable request.

Cited by (0)

3

These authors contributed equally

4

Present address: Biotechnology Research Center, Technology Innovation Institute, P.O. Box 9639, Abu Dhabi, United Arab Emirates

5

Present address: Department of Biological Sciences, Seoul National University, Seoul 08826, Republic of Korea

6

Lead contact